ClinicalTrials.Veeva

Menu
H

Health Care Family Rehab & Research Center | Hialeah, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pregabalin
Oxycodone
MLE4901
LF111
BMS-986446
Drospirenone
Bococizumab
Naloxone

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

The primary objective of this study is to evaluate the impact of LF111 and drospirenone (DRSP) 3.5 mg chewable tablets on bone mineral density (BMD)...

Enrolling
Change in Bone Mineral Density
Bone Loss
Drug: LF111 (drospirenone 4 mg oral tablet) or drospirenone (DRSP) 3.5 mg chewable tablet
Locations recently updated

The purpose of this study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants...

Enrolling
Alzheimer Disease, Early Onset
Other: Placebo
Drug: BMS-986446

Trial sponsors

Viatris logo
Bristol-Myers Squibb (BMS) logo
I
M
Pfizer logo
Purdue Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems